Asset Details
Do you wish to reserve the book?
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Do you wish to request the book?
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
2016
Overview
In recent years, type 2 diabetes mellitus has evolved as a rapidly increasing epidemic that parallels the increased prevalence of obesity and which markedly increases the risk of cardiovascular disease across the globe. While ischemic heart disease represents the major cause of death in diabetic subjects, diabetic cardiomyopathy (DC) summarizes adverse effects of diabetes mellitus on the heart that are independent of coronary artery disease (CAD) and hypertension. DC increases the risk of heart failure (HF) and may lead to both heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). Numerous molecular mechanisms have been proposed to underlie DC that partially overlap with mechanisms believed to contribute to heart failure. Nevertheless, the existence of DC remains a topic of controversy, although the clinical relevance of DC is increasingly recognized by scientists and clinicians. In addition, relatively little attention has been attributed to the fact that both underlying mechanisms and clinical features of DC may be partially distinct in type 1 versus type 2 diabetes. In the following review, we will discuss clinical and preclinical literature on the existence of human DC in the context of the two different types of diabetes mellitus.
Publisher
MDPI AG,MDPI
Subject
/ Coronary Artery Disease - epidemiology
/ Coronary Artery Disease - pathology
/ Diabetes
/ Diabetes Complications - pathology
/ Diabetes Mellitus, Type 1 - complications
/ Diabetes Mellitus, Type 2 - complications
/ Diabetic Cardiomyopathies - epidemiology
/ Diabetic Cardiomyopathies - pathology
/ Glycated Hemoglobin A - analysis
/ Humans
/ Ischemia
/ Review
